Different gene mutations in multiple myeloma depending on ancestry
November 24, 2017Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical
Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …
Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market
November 24, 2017Medical Communications Department of Justice, FDA, pharma
Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs …
AZ partners with Combinations Alliance to test drug in cancer
November 24, 2017Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical
A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …
Avatar therapy holds potential as adjunct therapy for schizophrenia
November 24, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, schizophrenia
Experts have developed a new form of therapy for patients living with schizophrenia, by allowing those individuals to speak to …
Drinking three cups of coffee found to hold health benefits
November 23, 2017Medical Communications biotech, coffee, drugs, pharma, pharmaceutical
In good news for coffee drinkers, drinking three to four cups of coffee was found to lower the risk of …
Learning lessons from HIV to change the treatment access landscape
November 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma
Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
Tesaro secures EU approval in specific ovarian cancer population
November 23, 2017Sales and Marketing Europe, European Commission, Tesaro, Zejula, pharma
The European Commission has granted Tesaro’s Zejula (niraparib) marketing approval in Europe, it has emerged. Zejula is a poly (ADP-ribose) …
Online GP appointments found to be largely ineffective
November 23, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
There is a general push in the UK to find new digital means of reducing the workload on doctors and …
Teva looks set to axe thousands of positions and a big name
November 23, 2017Manufacturing and Production Teva, biotech, drugs, pharma, pharmaceutical
Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news …
Autumn Budget provides NHS with much-needed winter cash boost
November 22, 2017Medical Communications Autumn Budget, biotech, drugs, pharma, pharmaceutical
The Autumn Budget was announced and one of the few major announcements that had not been leaked prior to the …
Collaboration in Biopharma
November 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds
November 22, 2017Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma
A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
‘Brain training’ found to reduce risk of dementia by 29%
November 22, 2017Research and Development biotech, dementia, drugs, pharma, pharmaceutical
In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
FDA approves first-ever two-drug HIV regimen, GSK’s Juluca
November 22, 2017Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma
GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
EU approves opioid treatment, amid fears of US-like crisis
November 22, 2017Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical
The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
Making careers in medcomms more visible – Synergy Vision launches new recruitment website
November 22, 2017Medical Communications Synergy Vision, csr, graduate recruitment, medical communcations, recruitment
“I’d never heard of med comms until I wanted to change career and started exploring my options” – it’s a …
Free Webinar: The End Game – Payer Engagement
November 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical
In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
Boehringer offers its molecules to the scientific community via new platform
November 21, 2017Manufacturing and Production, Research and Development Boehringer Ingelheim, pharma
Boehringer Ingelheim has unveiled opnME.com, a centralised platform which makes available selected pre-clinical molecules from its portfolio for free, accessible …
Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds
November 21, 2017Manufacturing and Production, Research and Development Cancer, breast cancer, pharma
A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …
NHS faced with 5,700% increase in drug price, finds CMA
November 21, 2017Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
